Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 58391 

Facility: Vitro Manufacturing. 

Location: Canonsburg, Pennsylvania. 

Job Titles and/or Job Duties: All 

employees who worked in any area. 

Period of Employment: January 1, 

1958 through April 30, 1960. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Interim Director, 

Division of Compensation Analysis and 

Support, National Institute for 

Occupational Safety and Health 

(NIOSH), 4676 Columbia Parkway, MS 

C–46, Cincinnati, OH 45226, Telephone 

877–222–7570. Information requests can 

also be submitted by e-mail to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2010–24011 Filed 9–23–10; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–10–0527] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam I. Daneshvar, 

CDC Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Human Exposure to Cyanobacterial 

Toxins in Water (OMB No. 0920–0527 

exp. 2/28/2011)—Revision—National 

Center for Environmental Health 

(NCEH), Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cyanobacteria (also called blue-green 

algae) can be found in terrestrial, fresh, 

brackish, or marine water environments. 

Some species of cyanobacteria produce 

toxins that may cause acute or chronic 

illnesses (including neurotoxicity, 

hepatotoxicity, and skin irritation) in 

humans and animals (including other 

mammals, fish, and birds). A number of 

human health effects, including 

gastroenteritis, respiratory effects, skin 

irritations, allergic responses, and liver 

damage, are associated with the 

ingestion of or contact with water 

containing cyanobacterial blooms. 

Although the balance of evidence, in 

conjunction with data from laboratory 

animal research, suggests that 

cyanobacterial toxins are responsible for 

a range of human health effects, there 

have been few epidemiologic studies of 

this association. 

In the first study of recreational 

microcystin (MC) exposure at a small 

lake, 104 study participants from lake 

visitors planning recreational activities 

that would generate aerosols were 

recruited, such as boating and using 

personal watercraft. During data 

collection for that study, MC 

concentrations within the bloom lake 

water were very low (<2–5 μg/L). Study 

participants’ plasma MC concentrations 

were all below the limit of detection 

(0.147 μg/L) for the enzyme-linked 

immunosorbent assay (ELISA). The 

second study of recreational exposure to 

microcystins involved 81 children and 

adults planning recreational activities 

on one of three California reservoirs, 

two with significant, ongoing blooms of 

toxin-producing cyanobacteria, 

including Microcystis aeruginosa 

(bloom lakes) and one without a toxinproducing algal bloom (control lake). 

Highly variable microcystin 

concentrations were found in bloom 

lakes (<10 μg/L to > 500 μg/L); 

microcystin was not detected in control 

lake samples. Neither adenoviruses nor 

enteroviruses were detected in any of 

the lakes. Low microcystin 

concentrations were found in personal 

air samples (< 0.1 ng/m3 [limit of 

detection]—2.89 ng/m3) and nasal 

swabs (< 0.1 ng [limit of detection]—5 

ng). Microcystin concentrations in the 

water-soluble fraction of all plasma 

samples were below the limit of 

detection (1.0 μg/L). Findings indicate 

that recreational activities in 

waterbodies experiencing toxinproducing cyanobacterial blooms can 

generate aerosolized cyanotoxins, 

making inhalation a potential route of 

exposure. 

Based on earlier work, it seems 

unlikely that recreational exposure to 

cyanobacteria toxins during algal 

blooms on small lakes will cause acute 

illness in people. However, there are 

occupational circumstances, such as 

using stagnant ponds to irrigate 

landscapes or golf courses and growing 

and harvesting catfish in standing 

ambient water ponds, where exposure to 

these toxins is likely to be greater than 

what have been observed during 

recreational activities. It is possible that 

these workers may be exposed to 

biologically relevant concentrations of 

cyanobacterial toxins while performing 

job-related activities. To address this 

concern, this proposal is to assess 

exposure of catfish farm workers to 

cyanobacteria toxins occurring in the 

standing water of catfish ponds in 

Alabama. Dr. Alan Wilson of Auburn 

University will be a collaborator. Dr. 

Wilson has considerable experience 

working with the catfish farmers to 

address how the presence of 

cyanobacteria in pond water can impact 

the taste and odor of catfish offered for 

sale to commercial markets. Since most 

of the ponds of interest tend to develop 

HABs comprising Microcystis 

aeruginosa, this study will be limited to 

exposure to microcystins. 

The purpose of the new data 

collection is to continue assessing the 

public health impact of exposure to the 

cyanobacterial toxins, microcystins. The 

extent of human exposure to 

microcystins present in catfish pond 

waters and associated aerosols and 

whether serum levels of microcystins 

can be used as a biomarker of exposure 

will be examined. 


srobinson on DSKHWCL6B1PROD with NOTICES
58392 Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

Catfish farm workers ...................................... Screening Questionnaire ............. 60 1 5/60 5 

Pre-exposure Questionnaire ....... 50 1 10/60 8 

Post-exposure Questionnaire ...... 50 4 10/60 33 

Total ........................................................ ...................................................... ........................ ........................ .................... 46 

Dated: September 20, 2010. 

Thelma E. Sims, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–24021 Filed 9–23–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Voluntary Customer 

Satisfaction Surveys To Implement 

Executive Order 12862 in the Substance 

Abuse and Mental Health Services 

Administration (SAMHSA)—(OMB No. 

0930–0197)—Extension 

Executive Order 12862 directs 

agencies that ‘‘provide significant 

services directly to the public’’ to 

‘‘survey customers to determine the kind 

and quality of services they want and 

their level of satisfaction with existing 

services.’’ SAMHSA provides significant 

services directly to the public, including 

treatment providers and State substance 

abuse and mental health agencies, 

through a range of mechanisms, 

including publications, training, 

meetings, technical assistance and Web 

sites. Many of these services are focused 

on information dissemination activities. 

The purpose of this submission is to 

extend the existing generic approval for 

such surveys. 

The primary use for information 

gathered is to identify strengths and 

weaknesses in current service 

provisions by SAMHSA and to make 

improvements that are practical and 

feasible. Several of the customer 

satisfaction surveys expected to be 

implemented under this approval will 

provide data for measurement of 

program effectiveness under the 

Government Performance and Results 

Act (GPRA). Information from these 

customer surveys will be used to plan 

and redirect resources and efforts to 

improve or maintain a high quality of 

service to health care providers and 

members of the public. Focus groups 

may be used to develop the survey 

questionnaire in some instances. 

The estimated annual hour burden is 

as follows: 

Type of data collection Number of 

respondents 

Responses/ 

respondent 

Hours/ 

response Total hours 

Focus groups ................................................................................................... 250 1 2.50 625 

Self-administered, mail, telephone and e-mail surveys ................................... 89,750 1 .250 22,438 

Total .......................................................................................................... 90,000 ........................ ........................ 23,063 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by October 25, 2010 to: 

SAMHSA Desk Officer, Human 

Resources and Housing Branch, Office 

of Management and Budget, New 

Executive Office Building, Room 10235, 

Washington, DC 20503; due to potential 

delays in OMB’s receipt and processing 

of mail sent through the U.S. Postal 

Service, respondents are encouraged to 

submit comments by fax to: 202–395– 

7285. 

Dated: September 16, 2010. 

Elaine Parry, 

Director, Office of Management, Technology 

and Operations. 

[FR Doc. 2010–23932 Filed 9–23–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and draft instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

Comments are invited on: (a) The 

proposed collection of information for 

the proper performance of the functions 

of the Agency; (b) the accuracy of the 


srobinson on DSKHWCL6B1PROD with NOTICES